Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
96.13
USD
|
-1.42%
|
|
+3.15%
|
+27.21%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,951
|
4,213
|
8,751
|
5,275
|
7,674
|
9,535
|
-
|
-
|
Enterprise Value (EV)
1 |
18,440
|
17,486
|
22,033
|
19,496
|
21,448
|
20,941
|
20,722
|
20,354
|
P/E ratio
|
-17
x
|
10.6
x
|
9.7
x
|
12.9
x
|
13.2
x
|
6.58
x
|
15.5
x
|
13.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.21
x
|
0.24
x
|
0.45
x
|
0.28
x
|
0.37
x
|
0.47
x
|
0.45
x
|
0.43
x
|
EV / Revenue
|
1
x
|
0.99
x
|
1.13
x
|
1.02
x
|
1.04
x
|
1.03
x
|
0.97
x
|
0.91
x
|
EV / EBITDA
|
6.81
x
|
5.56
x
|
6.33
x
|
5.62
x
|
6.06
x
|
6.16
x
|
5.77
x
|
5.31
x
|
EV / FCF
|
32.8
x
|
6.1
x
|
24.2
x
|
60.7
x
|
13.2
x
|
10.2
x
|
12.2
x
|
13.6
x
|
FCF Yield
|
3.05%
|
16.4%
|
4.13%
|
1.65%
|
7.57%
|
9.81%
|
8.23%
|
7.36%
|
Price to Book
|
-10.7
x
|
151
x
|
8.52
x
|
2.03
x
|
2.42
x
|
2.59
x
|
2.17
x
|
1.82
x
|
Nbr of stocks (in thousands)
|
103,895
|
105,517
|
107,126
|
108,123
|
101,552
|
99,186
|
-
|
-
|
Reference price
2 |
38.03
|
39.93
|
81.69
|
48.79
|
75.57
|
96.13
|
96.13
|
96.13
|
Announcement Date
|
2/24/20
|
2/9/21
|
2/7/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,479
|
17,640
|
19,485
|
19,174
|
20,548
|
20,332
|
21,256
|
22,385
|
EBITDA
1 |
2,706
|
3,146
|
3,483
|
3,469
|
3,541
|
3,399
|
3,589
|
3,831
|
EBIT
1 |
1,856
|
2,289
|
2,628
|
2,628
|
2,671
|
2,561
|
2,734
|
3,011
|
Operating Margin
|
10.04%
|
12.98%
|
13.49%
|
13.71%
|
13%
|
12.6%
|
12.86%
|
13.45%
|
Earnings before Tax (EBT)
1 |
296
|
671
|
1,888
|
1,344
|
1,617
|
2,463
|
1,721
|
1,809
|
Net income
1 |
-232
|
399
|
914
|
411
|
611
|
2,170
|
601.6
|
727
|
Net margin
|
-1.26%
|
2.26%
|
4.69%
|
2.14%
|
2.97%
|
10.67%
|
2.83%
|
3.25%
|
EPS
2 |
-2.240
|
3.750
|
8.420
|
3.790
|
5.710
|
14.60
|
6.194
|
6.932
|
Free Cash Flow
1 |
563
|
2,867
|
910
|
321
|
1,623
|
2,055
|
1,705
|
1,498
|
FCF margin
|
3.05%
|
16.25%
|
4.67%
|
1.67%
|
7.9%
|
10.11%
|
8.02%
|
6.69%
|
FCF Conversion (EBITDA)
|
20.81%
|
91.13%
|
26.13%
|
9.25%
|
45.83%
|
60.46%
|
47.5%
|
39.11%
|
FCF Conversion (Net income)
|
-
|
718.55%
|
99.56%
|
78.1%
|
265.63%
|
94.72%
|
283.41%
|
206.05%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/20
|
2/9/21
|
2/7/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
4,894
|
4,856
|
4,745
|
4,638
|
4,801
|
4,990
|
5,021
|
5,082
|
5,066
|
5,379
|
5,155
|
4,978
|
4,955
|
5,217
|
5,191
|
EBITDA
1 |
855
|
1,017
|
888
|
843
|
841
|
897
|
832
|
843
|
854
|
1,012
|
828
|
817.7
|
819.2
|
939.5
|
867.1
|
EBIT
1 |
646
|
816
|
685
|
627
|
632
|
684
|
615
|
630
|
630
|
796
|
618.5
|
612.5
|
609.3
|
722.9
|
662.9
|
Operating Margin
|
13.2%
|
16.8%
|
14.44%
|
13.52%
|
13.16%
|
13.71%
|
12.25%
|
12.4%
|
12.44%
|
14.8%
|
12%
|
12.3%
|
12.3%
|
13.86%
|
12.77%
|
Earnings before Tax (EBT)
1 |
774
|
528
|
378
|
265
|
380
|
321
|
380
|
373
|
345
|
519
|
392
|
395
|
407.7
|
502.3
|
427
|
Net income
1 |
448
|
249
|
140
|
38
|
131
|
102
|
143
|
123
|
101
|
244
|
1,822
|
137.3
|
136
|
209
|
163
|
Net margin
|
9.15%
|
5.13%
|
2.95%
|
0.82%
|
2.73%
|
2.04%
|
2.85%
|
2.42%
|
1.99%
|
4.54%
|
35.36%
|
2.76%
|
2.74%
|
4.01%
|
3.14%
|
EPS
2 |
4.120
|
2.290
|
1.280
|
0.3500
|
1.160
|
0.9200
|
1.320
|
1.150
|
0.9400
|
2.300
|
7.846
|
1.344
|
1.360
|
1.876
|
1.628
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/20/21
|
2/7/22
|
4/20/22
|
7/21/22
|
10/20/22
|
2/9/23
|
4/25/23
|
7/31/23
|
10/30/23
|
2/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
14,489
|
13,273
|
13,282
|
14,221
|
13,774
|
11,406
|
11,188
|
10,819
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.354
x
|
4.219
x
|
3.813
x
|
4.099
x
|
3.89
x
|
3.356
x
|
3.117
x
|
2.824
x
|
Free Cash Flow
1 |
563
|
2,867
|
910
|
321
|
1,623
|
2,055
|
1,705
|
1,498
|
ROE (net income / shareholders' equity)
|
6.98%
|
31.5%
|
173%
|
68.6%
|
44.4%
|
24.5%
|
17.4%
|
19.7%
|
ROA (Net income/ Total Assets)
|
1.23%
|
3.34%
|
3.34%
|
2.72%
|
2.2%
|
3.85%
|
2.2%
|
2.58%
|
Assets
1 |
-18,891
|
11,958
|
27,342
|
15,118
|
27,734
|
56,410
|
27,382
|
28,165
|
Book Value Per Share
2 |
-3.560
|
0.2600
|
9.590
|
24.00
|
31.20
|
37.10
|
44.30
|
52.70
|
Cash Flow per Share
2 |
11.90
|
32.10
|
14.40
|
9.800
|
22.70
|
18.70
|
17.70
|
18.80
|
Capex
1 |
670
|
540
|
658
|
762
|
751
|
812
|
825
|
859
|
Capex / Sales
|
3.63%
|
3.06%
|
3.38%
|
3.97%
|
3.65%
|
3.99%
|
3.88%
|
3.84%
|
Announcement Date
|
2/24/20
|
2/9/21
|
2/7/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
96.13
USD Average target price
111.7
USD Spread / Average Target +16.24% Consensus |
1st Jan change
|
Capi.
|
---|
| +27.21% | 9.53B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -3.97% | 11.66B | | -1.42% | 11.72B | | -31.75% | 11.77B |
Other Healthcare Facilities & Services
|